Evidence available on 21 September 2026
Targeted quoted-name discovery on 21 September 2026 did not establish a primary report for Slide +Lab Codrix. No working model, laboratory or performance series is authenticated by the available material. This limited outcome is not evidence of non-existence. We therefore publish no success percentage, historical return or conclusion about a strategy actually operating under the exact name.
A backtest claim would need a frozen specification
If a historical example is provided, ask which rules were fixed before the example was evaluated and which were adjusted afterward. The period, data version and exclusions should accompany the output. A changed rule set would describe a different exercise even if the chart retained the same title. These are questions for reading a future report, not an assertion that Slide +Lab Codrix offers backtesting or uses any particular method.
Evidence needed for a measured assessment
A useful submission would contain the complete methodology and the identity of the publisher responsible for it. That would make it possible to separate an illustrative result from a reproducible analysis. We have not inspected such a submission or compared it with live outcomes. The current finding remains unknown, and the technical impression created by Lab is not treated as a substitute for documents or measured evidence.